Literature DB >> 31463090

Predicting contrast induced nephropathy in patients undergoing percutaneous coronary intervention.

Rebecca Gosling1,2, Javaid Iqbal1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31463090      PMCID： PMC6688022          DOI： 10.21037/jtd.2019.06.48

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

1.  A simple pre-procedural risk score for contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention.

Authors:  Yong Liu; Yuan-Hui Liu; Ji-yan Chen; Ning Tan; Ying-ling Zhou; Hua-long Li; Wei Guo; Chong-yang Duan; Ping-yan Chen
Journal:  Int J Cardiol       Date:  2014-11-26       Impact factor: 4.164

2.  Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention.

Authors:  Dimitrios Tziakas; Georgios Chalikias; Dimitrios Stakos; Armagan Altun; Nasir Sivri; Ertan Yetkin; Mustafa Gur; Goran Stankovic; Zlatko Mehmedbegovic; Vassilis Voudris; Sofia Chatzikyriakou; Xavier Garcia-Moll; Antonio Serra; Ploumis Passadakis; Elias Thodis; Vassilis Vargemezis; Juan Carlos Kaski; Stavros Konstantinides
Journal:  Am J Cardiol       Date:  2014-02-12       Impact factor: 2.778

3.  Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice.

Authors:  Dimitrios Tziakas; Georgios Chalikias; Dimitrios Stakos; Stavros Apostolakis; Thomaidi Adina; Petros Kikas; Apostolos Alexoudis; Ploumis Passadakis; Elias Thodis; Vassilis Vargemezis; Stavros Konstantinides
Journal:  Int J Cardiol       Date:  2013-02-10       Impact factor: 4.164

4.  A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.

Authors:  Yong-Li Chen; Nai-Kuan Fu; Jing Xu; Shi-Cheng Yang; Shanshan Li; Yuan-Yuan Liu; Hong-Liang Cong
Journal:  Catheter Cardiovasc Interv       Date:  2013-09-30       Impact factor: 2.692

5.  Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention.

Authors:  Suma M Victor; Anand Gnanaraj; VijayaKumar S; Rajendra Deshmukh; Mani Kandasamy; Ezhilan Janakiraman; Ulhas M Pandurangi; K Latchumanadhas; Georgi Abraham; Ajit S Mullasari
Journal:  Indian Heart J       Date:  2014-06-10

6.  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

Authors:  Giancarlo Marenzi; Gianfranco Lauri; Emilio Assanelli; Jeness Campodonico; Monica De Metrio; Ivana Marana; Marco Grazi; Fabrizio Veglia; Antonio L Bartorelli
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

7.  Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.

Authors:  Mauro Maioli; Anna Toso; Michela Gallopin; Mario Leoncini; Delio Tedeschi; Carlo Micheletti; Francesco Bellandi
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-06       Impact factor: 2.160

Review 8.  Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis.

Authors:  Matthew T James; Susan M Samuel; Megan A Manning; Marcello Tonelli; William A Ghali; Peter Faris; Merril L Knudtson; Neesh Pannu; Brenda R Hemmelgarn
Journal:  Circ Cardiovasc Interv       Date:  2013-01-15       Impact factor: 6.546

9.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

Review 10.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Authors:  Steven D Weisbord; Martin Gallagher; James Kaufman; Alan Cass; Chirag R Parikh; Glenn M Chertow; Kendrick A Shunk; Peter A McCullough; Michael J Fine; Maria K Mor; Robert A Lew; Grant D Huang; Todd A Conner; Mary T Brophy; Joanne Lee; Susan Soliva; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.